| David J. Daniels, M.D., Ph.D., principal investigator |
Therapeutic Targets for Diffuse Intrinsic Pontine Gliomas |
American Brain Tumor Association/Humor to Fight the Tumor |
03/1/2017-02/28/2018 |
| K Sreekumaran Nair, M.D., Ph.D., investigator |
Evaluating Glutamine Metabolism in Pediatric High-Grade Gliomas With the H3K27M Mutation |
Mayo Clinic Metabolomics Resource Core through grant number U24DK100469 from the National Institute of Diabetes and Digestive and Kidney Diseases and originates from the National Institutes of Health Director's Common Fund |
06/01/2016-05/31/2017 |
| Brian Patrick O'Neill, M.D., principal investigator |
Targeting the Epigenome of Pediatric Brain Tumors |
Developmental Research Project Award through Mayo Brain Spore, National Cancer Institute (P50 CA 10896) |
06/01/2016-10/31/2016 |
| David J. Daniels, M.D., Ph.D., principal investigator |
Targeting Glutamine Metabolism in Pediatric High-Grade Gliomas with the H3K27M Mutation |
Brains Together for a Cure |
06/01/2016-05/31/2017 |
| David J. Daniels, M.D., Ph.D., principal investigator |
Chemical Screen to Identify Lead Compounds for Treating Pediatric High-Grade Gliomas with H3.3K27M Mutations |
Sanford Burnham — Mayo Clinic, Partnership for Drug Discovery and Development Award |
02/01/2015-02/01/2017 |
| Brian Patrick O'Neill, M.D., principal investigator |
Development of STAT3 Inhibitors for Malignant Brain Tumors |
Career Development Award through Mayo Brain Spore, National Cancer Institute (P50 CA 108961) |
06/30/2014-10/31/2016 |
| David J. Daniels, M.D., Ph.D., principal investigator |
Evaluation of Novel STAT3 Inhibitors for Treatment of Malignant Pediatric Brain Tumors |
Shainberg Neuroscience Research Fund |
11/01/2013-12/31/2014 |
| David J. Daniels, M.D., Ph.D., principal investigator |
Development and Refinement of Novel STAT3 Inhibitors for Malignant Brain Tumor Treatment |
Brains Together for a Cure |
07/01/2012-07/01/2014 |